Innate immunity, allergy and atopic dermatitis

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 5, 2010, Pages 463-468

  Niebuhr, Margarete ^a   Werfel, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antimicrobial peptides; atopic dermatitis; epithelial barrier defect; filaggrin; innate immunity

Indexed keywords

CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 4; SKIN LIPID;

ADAPTIVE IMMUNITY; ALLERGY; ATOPIC DERMATITIS; CYTOKINE PRODUCTION; HUMAN; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; INFECTION SENSITIVITY; INNATE IMMUNITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TH2 CELL;

ANTIMICROBIAL CATIONIC PEPTIDES; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INFECTION; LIPID METABOLISM; SIGNAL TRANSDUCTION; SKIN; TH1-TH2 BALANCE;

EID: 77956247801     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833e3163     Document Type: Review

References (55)

1. Cork MJ, Robinson DA, Vasolopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118:3-21.
2. Boguniewicz M, Leung DYM. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Im munol 2010; 125:4-13.
3. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and mmunol-ogy/PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118:152-169.
4. De Benedictis FM, Franceschini F, Hill D, et al. The allergic sensitization in infants with atopic eczema from different countries. Allergy 2009; 64:295-303.
5. Kapoor R, Menon C, Hoffstad O, et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008; 58:68-73.
6. Breuer K, Kapp A, Werfel T. Bacterial infections and atopic dermatitis. Allergy 2001; 56:1034-1041.
7. Matsui K, Nishikawa A, Suto H, et al. Comparative study of Staphylococcus aureus isolated from lesional and nonlesional skin of atopic dermatitis. Microbiol Immunol 2000; 44:945-947.
8. Leyden LE, Marples RR, Kligmann AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90:525-530.
9. Leung DYM, Bieber T. Atopic dermatitis. Lancet 2003; 361:151-160.
10. Guzik TJ, Bzowska M, Kasprowicz A, et al. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 2005; 35:448-455.
11. Breuer K, Haussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002; 147:55-61.
12. Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13:16-34.
13. Schlievert PM, Case LC, Strandberg KL, et al. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis 2008; 46:1562-1567.
14. Breuer K, Wittmann M, Kempe K, et al. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy 2005; 35:1088-1095.
15. Wichmann K, Uter W, Weiss J, et al. Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 2009; 161:300-305.
16. This study shows a high rate of alpha-toxin producing S. aureus strains in atopic dermatitis. Peng WM, Jenneck C, Bussmann C, et al. Risk factors of atopic dermatitis patients for eczema herpeticatum. J Invest Dermatol 2007; 127:1261-1263.
17. Howell MD, Wollenberg A, Gallo RL, et al. Cathelicidin deficiency predisposes to eczema herpeticatum. J Allergy Clin Immunol 2006; 117:836-841.
18. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120:150-155.
19. De Benedetto A, Agnihothri R, McGirt LY, et al. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009; 129:14-30.
20. Morr M, Takeuchi O, Akira S, et al. Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. Eur J Immunol 2002; 32:3337-3347.
21. Takeuchi O, Kawai T, Muhlradt PF, et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13:933-940.
22. Girardin SE, Travassos LH, Herve M, et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003; 43:41702-41708.
23. Visser L, Melief M, Van Riel D, et al. Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. Am J Pathol 2006; 169:1671-1685.
24. Travers JB, Kozman A, Mousdicas N, et al. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J Allergy Clin Immunol 2010; 125:146-152.
25. Niebuhr M, Lutat C, Sigel S, Werfel T. Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis. Allergy 2009; 64:1580-1587.
26. Chisholm D, Libet L, Hayashi T, Horner AA. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities. J Allergy Clin Immunol 2004; 113:448-454.
27. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, et al. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004; 113:565-567.
28. Lorenz E, Mira JP, Cornish KL. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infections. Infect Immunol 2000; 68:6398-6401.
29. Niebuhr M, Langnickel J, Begemann G, et al. Dysregulation of TLR-2 induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism. Allergy 2008; 63:728-734.
30. Niebuhr M, Langnickel J, Sigel S, Werfel T. Dysregulation of CD36 upon TLR-2 stimulation in monocytes from patients with atopic dermatitis and the TLR-2 R753Q polymorphism. Exp Dermatol 2010; 19:e296-e298.
31. Weidinger S, Novak N, Klopp N, et al. Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema. J Allergy Clin Immunol 2006; 118:277-279.
32. Oh DY, Schumann RR, Hamann L, et al. Association of the toll-like receptor 2 A-16934 T promoter polymorphism with severe atopic dermatitis. Allergy 2009; 64:1608-1615.
33. Munoz-Planillo R, Franchi L, Miller LS, Nunez G. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the NLRP3 inflammasome. J Immunol 2009; 183:3942-3948.
34. KatsutaM,Takigawa Y, KimishimaM, et al. NK cells and gamma delta+T cells are phenotypically defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 2006; 176:7736-7744.
35. Lebre MC, Van Capel TM, Bos JD, et al. Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients. J Allergy Clin Immunol 2008; 122:969-976.
36. Tversky JR, Le TV, Bienemann AP, et al. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin Exp Allergy 2008; 38:781-788.
37. Schroeder JT, Bienemann AP, Xiao H, et al. TLR-9 and FceRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J Immunol 2005; 175:5724-5731.
38. Novak N, Valenta R, Bohle B, et al. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 2004; 113:949-957.
39. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441-446.
40. Rupec R, Boneberger S, Ruzicka T. What is really in control of skin immunity: lymphocytes, dendritis cells, or keratinocytes? Facts and controversies. Clin Dermatol 2010; 28:62-66.
41. Rodriguez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009; 123:1361-1370.
42. McLean WH, Palmer CN, Henderson J, et al. Filaggrin variants confer susceptibility to asthma. J Allergy Clin Immunol 2008; 121:1294-1296.
43. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008; 122:689-693.
44. Henderson J, Northstone K, Lee SP, et al. The burden of diseases associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008; 121:872-877.
45. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated byTh2 cytokines through STAT-6.Clin Immunol 2008; 126:332-337.
46. Beck LA, Boguniewicz M, Hata T, et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticatum. J Allergy Clin Immunol 2009; 124:260-269.
47. Gao PS, Rafaels NM, Mu D, et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpetica-tum. J Allergy Clin Immunol 2010; 125:1403-1407.
48. Gao PS, Rafaels NM, Hand T, et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticatum. J Allergy Clin Immunol 2009; 124:507-513.
49. Oyoshi MK, Murphy GF, Geha RS. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigens. J Allergy Clin Immunol 2009; 124:494-495.
50. Sator PG, Schmidt JB, Honigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 2003; 48:352-358.
51. ArikawaJ, Ishibashi M, KawashimaM, et al. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002; 119:433-439.
52. Harder J, Dressel S, Wittersheim M, et al. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010; 130:1355-1364.
53. Kisich KO, Carspecken CW, Fieve S, et al. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol 2008; 122:62-68.
54. Hata TR, Kotol P, Jackson M, et al. Administration of oral vitamin D induced cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008; 122:928-930.
55. Eyerich K, Pennino D, Scarponi C, et al. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 2009; 123:59-66.